IMPORTANCE OF URIC ACID LEVEL AS A RISK FACTOR FOR PROGRESSION OF IGA NEPHROPATHY

被引：0
|
作者：
Chin, Ho-Jun [1 ]
Na, Ki Young [2 ]
Chae, Dong-Wan [2 ]
Kim, Suhnggwon [3 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Seoul 151, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seoul 151, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A32 / A32
页数：1
相关论文
共 50 条
  • [21] URINARY NGAL AND RISK FOR PROGRESSION IN IGA NEPHROPATHY PATIENTS
    Xidakis, Dimitris
    Antonaki, Ergini
    Tzanakakis, Michail
    Kostakis, Kostas
    Galani, Despoina
    Tzagarakis, Emmanouil
    Daphnis, Eugenios
    Papadogiannakis, Apostolos
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 379 - 380
  • [22] Predicting Progression of IgA Nephropathy: New Clinical Progression Risk Score
    Xie, Jingyuan
    Kiryluk, Krzysztof
    Wang, Weiming
    Wang, Zhaohui
    Guo, Shanmai
    Shen, Pingyan
    Ren, Hong
    Pan, Xiaoxia
    Chen, Xiaonong
    Zhang, Wen
    Li, Xiao
    Shi, Hao
    Li, Yifu
    Gharavi, Ali G.
    Chen, Nan
    PLOS ONE, 2012, 7 (06):
  • [23] DIETARY ZINC IS AN IMPORTANT ENVIRONMENTAL FACTOR IN THE PROGRESSION OF IgA NEPHROPATHY
    Masayuki, Maiguma
    Yusuke, Suzuki
    Hitoshi, Suzuki
    Keiko, Okazaki
    Masashi, Aizawa
    Masahiro, Muto
    Yasuhiko, Tomino
    NEPHROLOGY, 2014, 19 : 147 - 147
  • [24] Uric Acid and CKD Progression Matures with Lessons for CKD Risk Factor Discovery
    Oluwo, Oluwaseun
    Scialla, Julia J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (03): : 476 - 478
  • [25] Stratifying risk for progression in IgA nephropathy: how to predict the future?
    Rafalska, Agnieszka
    Franczuk, Jolanta
    Franczuk, Pawel
    Augustyniak--Bartosik, Hanna
    Krajewska, Magdalena
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2014, 124 (7-8): : 365 - 372
  • [26] Epidemiology and risk factors for progression in Chinese patients with IgA nephropathy
    Liu, Yang
    Wei, Wei
    Yu, Chengyuan
    Xing, Li
    Wang, Mingao
    Liu, Ruichan
    Ma, Jing
    Liu, Xiaogang
    Xie, Rujuan
    Sui, Manshu
    MEDICINA CLINICA, 2021, 157 (06): : 267 - 273
  • [27] Treatment strategy for IgA nephropathy depends on the risk of disease progression
    Drugs & Therapy Perspectives, 1999, 13 (1) : 5 - 8
  • [28] Histopathologic Features Aid in Predicting Risk for Progression of IgA Nephropathy
    Walsh, Michael
    Sar, Aylin
    Lee, Diane
    Yilmaz, Serdar
    Benediktsson, Hallgrimur
    Manns, Braden
    Hemmelgarn, Brenda
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (03): : 425 - 430
  • [29] An evaluation of the roles of hematuria and uric acid in defining the prognosis of patients with IgA nephropathy
    Ron Hogg
    Pediatric Nephrology, 2022, 37 : 947 - 958
  • [30] Modulating the progression in IgA nephropathy
    Chan, James C. M.
    Trachtman, Howard
    NEPHRON CLINICAL PRACTICE, 2006, 104 (01): : C61 - C68
12345